High-dose intravenous anakinra treatment is safe and effective in severe and critical COVID-19 patients: a propensity score-matched study in a single center

BACKGROUND: In COVID-19, severe disease course such as need of intensive care unit (ICU) as well as development of mortality is mainly due to cytokine storm. In this study, we aimed to evaluate the high-dose intravenous anakinra treatment response and outcome in patients with severe and critically i...

Descripción completa

Detalles Bibliográficos
Autores principales: Bektaş, Murat, Yüce, Servet, Ay, Mustafa, Uyar, Muhammed Hamdi, Önder, Mustafa Erkut, Kılıç, Muhammed İkbal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882740/
https://www.ncbi.nlm.nih.gov/pubmed/36707494
http://dx.doi.org/10.1007/s10787-023-01138-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882740/
https://www.ncbi.nlm.nih.gov/pubmed/36707494
http://dx.doi.org/10.1007/s10787-023-01138-8

Ejemplares similares